BackMillendo Therapeutics Overview

Millendo Therapeutics Other Income Expense Net

Other Income/Expense Net for MLND.

Quarterly Other Income/Expense

$23000.00
↓ 69.74% YoY

As of Mar 31, 2026

Annual Other Income/Expense (TTM)

-$53000.00
↑ 99.87% YoY

Trailing 12 months ending Mar 31, 2026

Average Other Income/Expense (Comparison Companies)

Other Income Expense Net History

Other Income Expense Net Comparison

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin